Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Nov 23, 2023
Date Accepted: Aug 26, 2024

The final, peer-reviewed published version of this preprint can be found here:

The Role of Smartwatch Technology in the Provision of Care for Type 1 or 2 Diabetes Mellitus or Gestational Diabetes: Systematic Review

Alvarez S, Fellas A, Wynne K, Santos D, Sculley D, Acharya S, Navathe P, Girones X, Coda A

The Role of Smartwatch Technology in the Provision of Care for Type 1 or 2 Diabetes Mellitus or Gestational Diabetes: Systematic Review

JMIR Mhealth Uhealth 2024;12:e54826

DOI: 10.2196/54826

PMID: 39625868

PMCID: 11629918

The role of SmartWatch Technology in the provision of care for type 1 or 2 Diabetes Mellitus or Gestational Diabetes: a systematic review.

  • Sergio Alvarez; 
  • Antoni Fellas; 
  • Katie Wynne; 
  • Derek Santos; 
  • Dean Sculley; 
  • Shamasunder Acharya; 
  • Pooshan Navathe; 
  • Xavier Girones; 
  • Andrea Coda

ABSTRACT

Background:

The use of Smart technology in the management of all forms of diabetes mellitus has grown significantly in the past ten years. Technologies such as the SmartWatch have been proposed as a method of assisting in the monitoring of blood glucose levels as well as other alert prompts such as medication adherence and daily physical activity targets. These important outcomes reach across all forms of diabetes and have the potential to increase compliance of self-monitoring with the aim of improving long term outcomes such as HbA1c.

Objective:

This systematic review aims to explore the literature for evidence of SmartWatch technology in type 1,2 and gestational diabetes.

Methods:

A systematic review was undertaken by searching Ovid MEDLINE and CINAHL databases. A second search using all identified keywords and index terms was performed on Ovid MEDLINE (January 1966 to August 2023), EMBASE (January 1980 to August 2023), Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library, latest issue), CINAHL (from 1982), IEEE Xplore, and ACM Digital Libraries, and Web of Science databases.

Results:

Five studies were included for qualitative synthesis in this review, however, none of these studies were randomised clinical trials and published research is currently focusing on usability and feasibility.

Conclusions:

This systematic review has highlighted the lack of robust randomised clinical trials that explore the efficacy of SmartWatch technology in the management of patients with type 1, 2 and gestational diabetes.


 Citation

Please cite as:

Alvarez S, Fellas A, Wynne K, Santos D, Sculley D, Acharya S, Navathe P, Girones X, Coda A

The Role of Smartwatch Technology in the Provision of Care for Type 1 or 2 Diabetes Mellitus or Gestational Diabetes: Systematic Review

JMIR Mhealth Uhealth 2024;12:e54826

DOI: 10.2196/54826

PMID: 39625868

PMCID: 11629918

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.